Stat is reporting that the Food and Drug Administration has delayed its issuing of a final rule that would let drug manufacturers update the safety warnings on their products independently, rather than seeking FDA approval to do so. The report notes that this is the second time the FDA final rule issuance has been delayed since the rule was proposed in 2013. The proposed rule has been met with opposition from such organizations as CVS and various groups representing manufacturers, pharmacists and wholesalers due to the number of different labels that would come out of the rule. (Stat)
The message said that for patients with sinusistis, bronchitis and uncomplicated urinary tract infections who have other treatment options, the possible side effects of fluoroquinolone antibiotics outweigh the benefits.
Pharmacy industry consultant Bruce Kneeland and his wife are embarking on a 5,000-mile road trip to visit 12 pharmacies in middle America, taking a look at how they’re thriving despite challenges facing independent pharmacy owners.
The agreement will allow pharmacies to provide full-service specialty offerings for patients with complex chronic conditions and it will see Diplomat providing 24/7 access to specialty pharmacists and technicians.
The National Association of Chain Drug Stores Total Store Expo has announced participants of its Vision 2027 attraction at the 2016 TSE, which will be held Aug. 6-9 at the Boston Convention & Exhibition Center.
In the 2015 State of the Union address, President Barack Obama announced the launch of the Precision Medicine Initiative — a bold new research effort that can be actuated by MD Labs' Rxight, a pharmacogenetic program.
PhRMA said that the money poured into research has led to more medicines in clinical development than ever before and that the Food and Drug Administration has approved 550 medicines between 2000 and 2015.